Modelling cost-effectiveness and value of information in clinical trials to inform stop go decisions: results from the arctic study

被引：0
|
作者：
Smith, Alison [1 ]
Hall, Peter [2 ]
O'Dwyer, John [1 ]
Hulme, Claire [1 ]
Cohen, Dena [1 ]
Gregory, Walter [1 ]
机构：
[1] Univ Leeds, York, N Yorkshire, England
[2] Univ Edinburgh, Edinburgh, Midlothian, Scotland
来源：
TRIALS | 2015年 / 16卷
关键词：
Chronic Lymphocytic Leukaemia; Mitoxantrone; Interim Analysis; Fludarabine; Health Loss;
D O I：
10.1186/1745-6215-16-S2-O27
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
O27
引用
收藏
页数：1
相关论文
共 50 条
  • [41] PAEDIATRIC USE MARKETING AUTHORISATION (PUMA): THE CHALLENGES OF COST-EFFECTIVENESS MODELLING WHERE LIMITED CLINICAL TRIAL INFORMATION IS AVAILABLE
    Gladwell, D.
    Lee, D.
    Tate, E.
    Batty, A.
    Brereton, N. J.
    VALUE IN HEALTH, 2012, 15 (07) : A323 - A323
  • [42] Improving the efficiency of cost-effectiveness analysis to inform policy decisions in the real world: lessons from the Pharmacoeconomics Research Unit at Cancer Care Ontario
    Jeffrey S Hoch
    BMC Health Services Research, 14 (Suppl 2)
  • [43] Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study
    Kenworthy, James
    Yi, Yunni
    Wright, Antony
    Brown, Jim
    Madrigal, Ana Maria
    Dunlop, William C. N.
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (07) : 740 - 748
  • [44] Cost-effectiveness of HPV-based cervical screening based on first year results in the Netherlands: a modelling study
    Jansen, E. E. L.
    Naber, S. K.
    Aitken, C. A.
    de Koning, H. J.
    van Ballegooijen, M.
    de Kok, I. M. C. M.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 128 (03) : 573 - 582
  • [45] Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal
    Raymond Hutubessy
    Ana Maria Henao
    Pem Namgyal
    Vasee Moorthy
    Joachim Hombach
    BMC Medicine, 9
  • [46] Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal
    Hutubessy, Raymond
    Henao, Ana Maria
    Namgyal, Pem
    Moorthy, Vasee
    Hombach, Joachim
    BMC MEDICINE, 2011, 9
  • [47] Protocol for a modelling study to assess the clinical and cost-effectiveness of indefinite anticoagulant therapy for first unprovoked venous thromboembolism
    Khan, Faizan
    Thavorn, Kednapa
    Coyle, Doug
    van Katwyk, Sasha
    Tritschler, Tobias
    Hutton, Brian
    Le Gal, Gregoire
    Rodger, Marc
    Fergusson, Dean
    BMJ OPEN, 2023, 13 (01):
  • [48] Cost-effectiveness analysis in glaucoma:: what drives utility?: Results from a pilot study in Sweden
    Kobelt, Gisela
    Jonsson, Bjorn
    Bergstrom, Anders
    Chen, Enping
    Linden, Christina
    Alm, Albert
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2006, 84 (03): : 363 - 371
  • [49] Cost-effectiveness of the implantable cardioverter defibrillator: Results from the Canadian Implantable Defibrillator Study (CIDS)
    O'Brien, B
    Connolly, S
    Goeree, R
    Blackhouse, G
    Willan, A
    Yee, R
    Roberts, R
    Gent, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 152A - 153A
  • [50] From accuracy to patient outcome and cost-effectiveness evaluations of diagnostic tests and biomarkers: an exemplary modelling study
    Koffijberg, Hendrik
    van Zaane, Bas
    Moons, Karel G. M.
    BMC MEDICAL RESEARCH METHODOLOGY, 2013, 13
12345